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Opinion statement
Aortic valve disease and especially aortic stenosis (AS) is a growing cardiac pathology.
Aortic valve replacement (AVR) is still the only treatment with proven benefit on survival in
symptomatic patients and in patients with a left ventricular ejection fraction (LVEF) G50%.
The benefit of prophylactic AVR in asymptomatic patients is still unproven. Once symptoms
develop, the prognosis worsens. Exercise testing has emerged as a tool to unmask the
“pseudo-asymptomatic” patients with AS (those without self-reporting symptoms), to link
“exercise induced dyspnea” more confidently and more objectively to aortic valve disease
and to allow for a safe “watchful waiting strategy” in “pseudo-symptomatic” patients (those
with dyspnea unrelated to aortic valve disease). In cases in which exercise testing is unable
to link dyspnea to aortic valve disease, exercise stress echocardiography and cardiopulmo-
nary exercise testing may be helpful. Whatever the results of exercise testing with regard to
symptom development, an increase in mean aortic valve pressure gradient 918–20 mmHg
was associated with an increased risk of cardiac related events in severe AS patients (class
IIb indication for AVR in the ESC guidelines). The decrease in LVEF during exercise as well as
the development of exercise induced pulmonary hypertension, as revealed by exercise stress
echocardiography, may be also useful in the risk stratification of these asymptomatic
patients with severe AS. Data on the role of exercise echocardiography in asymptomatic
severe aortic regurgitation patients is still scarce and further studies are needed. It seems
that an exercise induced decrease in LVEF by 5% may be a better predictor of LV systolic
dysfunction after AVR in asymptomatic patients or in patients with minimal symptoms.
Exercise testing and exercise echocardiography are safe in the asymptomatic patients with
aortic disease, provide useful clinical information that may help in risk assessment of these
complicated patients and their use should be encouraged especially in heart valve clinics.
Introduction
Significant aortic valve disease (more than moderate
aortic stenosis or/and aortic regurgitation) affects be-
tween 2.8 and 4.8% of adults older than 75 years in
the USA [1]. Aortic valve replacement (AVR) is the only
treatment with proven benefit on survival in symptom-
atic patients (symptoms reported spontaneously or de-
veloped during exercise testing) and in patients with a
left ventricular ejection fraction (LVEF) G50% [2, 3].
When the presenting symptom in patients with aor-
tic stenosis (AS) is “exercise induced dyspnea,” it is
challenging to establish whether the symptom is clearly
related to the valve disease. On the other hand, elderly
patients with severe AS tend to unconsciously lower
their level of physical activity to avoid symptoms (“pseu-
do-asymptomatic” patients) and therefore, tend to re-
port symptoms too late. Some patients deny symptoms.
Exercise testing has emerged as a tool to unmask the
“pseudo-asymptomatic” patients with severe AS, and to
link “exercise induced dyspnea” to the severity of valve
disease. Still, even in the era of exercise testing, linking
accurately exercise induced dyspnea to valve disease can
be difficult, especially in patients with other comorbid-
ities, such as obesity, chronic pulmonary obstructive
disease, and physical deconditioning. Even in the ab-
sence of comorbidities, self-reported exercise induced
dyspnea may be subjective, some patients (i.e., seden-
tary patients) reporting dyspnea during physical activi-
ties even when valve disease is only moderate. If clear
evidence in favor of early prophylactic AVR in truly
asymptomatic severe AS were available, exercise testing
would be used only to detect early “pseudo-asymptom-
atic” patients, since once symptoms have developed, the
risk of sudden death and the surgical risk are both
increasing. However, the controversy of “early prophy-
lactic AVR” in truly asymptomatic severe AS is not yet
solved. Therefore, exercise testing in severe AS patients is
performed to unmask “pseudo-asymptomatic patients”
as well as to allow a safe “watchful waiting” strategy in
“pseudo-symptomatic” patients (patients with severe AS
but with dyspnea unrelated to valve disease). When
exercise testing does not reveal symptoms, exercise stress
echocardiography (ESE) and cardiopulmonary exercise
testing (CPET) may be helpful for risk stratification of
asymptomatic patients. This current review will cover
shortly what is already established regarding exercise
testing and exercise imaging in aortic valve disease, but
will also give an update on what is new in this setting.
Exercise testing in AS will be covered first, leaving at the
end the less studied topic of exercise testing in aortic
regurgitation (AR).
Current guideline recommendations on exercise testing
Exercise testing has been advocated by the ESC guidelines on the management
of valvular heart disease to “unmask the objective occurrence of symptoms in
patients who claim to be asymptomatic or have doubtful symptoms.” [3]. No
other specific recommendations are made regarding exercise testing and severe
AR in the 2012 ESC guidelines [3]. In patients with severe AS specifically, the
ESC guidelines emphasize that exercise testing “is recommended in physically
active patients for unmasking symptoms and in the risk stratification of asymp-
tomatic [ones]” [3].
In the 2014 ACC/AHA guidelines, exercise testing receives an “overall” class
IIa indication (reasonable in selected patients) for the management of patients
with asymptomatic valvular heart disease to “(1) confirm the absence of symp-
toms, or (2) assess the hemodynamic response to exercise, or (3) determine
prognosis” [2].With regard to severe AS, the ACC/AHA guidelines give a class IIa
indication for exercise testing in asymptomatic patients with high gradient AS
(stage C), with the purpose to confirm the absence of symptoms, while no
specific class indication ismade in patients with severe AR, in whom, guidelines
state that “exercise stress testing can be used to assess symptomatic status and
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functional capacity and is helpful in confirming patients’ reports that they have
no symptoms with daily life activities and in assessing objective exercise capac-
ity and symptom status in those with equivocal symptoms.” [2].
Overall, because of the paucity of convincing data available up to now, both
the ESC and the ACC/AHA guidelines give no specific class indication for
exercise testing in asymptomatic patients with severe AR, nor a specific class
indication for AVR if symptoms have been unmasked by exercise testing.
For severe AS, there is a class I indication for AVR in patients who develop
symptoms during an exercise test in both guidelines. Moreover, the ESC guide-
lines emphasize that symptom development during exercise testing should be
clearly related to AS. A class IIa indication for AVR is present in both guidelines
if the patient has a drop in blood pressure values below baseline with exercise
testing. However, a slight difference exists between the two guidelines with the
American guideline including “decreased exercise tolerance” into the definition
of “abnormal exercise test,” and therefore as a class IIa indication for AVR, while
for the European guidelines only the drop in blood pressure is considered as an
abnormal response to exercise testing [2, 3].
To note, ventricular arrhythmias during exercise [4, 5], ≥2 mm ST segment
depression [4, 6], less than 20 mmHg increase in blood pressure values during
exercise [4, 6],mean gradient increase of 918–20mmHg [5, 6] with exercise and
exercise induced fall in LVEF [7] have been shown to be predictive of sponta-
neous symptoms onset [4–6], symptom-driven AVR [5, 6], and sudden cardiac
death [5, 6]. However, due to the relatively weak evidence available, most of
these abnormal findings during exercise testing carry no indication for AVR,
with the exception of an increase in mean gradient with exercise of 920 mmHg
which is a class IIb indication for AVR only in the ESC guidelines.
Clinical practice issues/problems
Angina, syncope, pre-syncope during exercise are easy to recognize and link to
valve disease. However, they are rather rare in the AS population undergoing
exercise testing. Virtually, all patients with severe AS performing an exercise test
will end up being dyspneic at the end of the test. What is challenging is to
recognize what represents “pathological dyspnea”, and link it to valve disease.
One would argue that dyspnea developing in the early stages of exercise testing
is to be considered pathological and very likely related to valve disease. Much
more challenging is to judge whether dyspnea arising in the mid-late stages of
an exercise test is to be considered pathological, especially in untrained/
deconditioned subjects or subjects with multiple comorbidities. With this
aim, ESE and CPET have been studied in patients with severe AS.
What is known
Whatever the results of the exercise test with regard to symptom development,
an increase inmean aortic pressure gradient by 918 to 20mmHgduring exercise
was associated with an increased risk of cardiac-related events in 2 studies [5,
6].Our group was the first to report, in a series including 69 consecutive patients
with asymptomatic severe AS and normal LV function that a significant increase
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inmean gradient with exercisemay be amarker of worse prognosis [6]. Patients
with marked exercise-induced increase in mean aortic pressure gradient had
significantly worse cardiac event-free survival (around 80% of events at 2-year
follow-up). Although patients who experienced an event during the follow-up
had no significant difference in mean aortic pressure gradient at rest, as com-
pared to those without an event (41 ± 12 mmHg vs. 38 ± 9 mmHg), they
exhibited a significantly higher exercise-induced increase in mean gradient
(Δ23 ± 8 mmHg vs. Δ12 ± 7 mmHg). This parameter provided incremental
prognostic value over resting echocardiographic data and exercise electrocar-
diogram. Similar results have been found in a multi-centric study which en-
rolled 186 “truly” asymptomatic patients (i.e., without abnormality during an
exercise test) with at least moderate AS (AVA G 1.5 cm2) [5]. In this study, an
exercise-induced increase in mean aortic pressure gradient 920 mmHg was
independently associated with a 3.8-fold increase in risk of cardiac events,
regardless of age, exercise LV ejection fraction, or resting mean aortic pressure
gradient. Interestingly, this marked increase in mean gradient during exercise
(i.e., 918 to 20 mmHg) was encountered in 35 and 21%, respectively, of the
studied population in these two studies [5, 6]. This “pathological” increase in
pressure gradient during exercisemay reflect the presence of either amore severe
AS (the more severe the stenosis at rest, the higher the increase in gradient for a
given flow rate during exercise) and/or a noncompliant, rigid aortic valve (no or
minimal improvement of aortic valve orifice opening during exercise).The
exercise-induced changes in mean aortic pressure gradient should, however,
be analyzed in the light of the exercise-induced changes in LV stroke volume.
Indeed, a marked increase in LV stroke volume in response to exercise may
directly influence the aortic mean pressure gradient, even in the presence of a
compliant aortic valve with a certain degree of opening reserve. In contrast, in
highly calcified aortic stenosis, without improvement in aortic valve area during
exercise, mild increase in LV stroke volume may produce as well significant
changes in mean aortic pressure gradient.
Of similar clinical interest and equally feasible with exercise echocardiogra-
phy is the assessment of LV function during exercise. It has been shown that
patients with a decrease or a small increase in LV ejection fraction during
exercise are more likely to exhibit an abnormal response to exercise and
cardiac-related events during follow-up [7, 8]. In the study by Marechaux
et al. [7], absence of LV contractile reserve defined as no increase or reduction
of LV ejection fraction with exercise was associated with more frequent abnor-
malities, with development of symptoms during exercise and with markedly
reduced midterm cardiac event-free survival (around 40% at 2-year follow-up).
Furthermore, abnormal response to exercise (excessive symptoms, fall or
G20 mmHg increase in systolic blood pressure, and 92 mm ST-segment depres-
sion) was associated with the decrease/mild increase of LV ejection fraction
during exercise [9]. With 2D speckle tracking analysis, Donal et al. reported a
threshold of −1.4% in exercise-induced changes in LV global longitudinal strain
as an accurate marker of the presence of LV contractile reserve [8]. However, it
should be emphasized that these studies are based on relatively small sample
sizes and the cut-off values were not validated against patients’ outcome.
In severe AS, elevated SPAP and the presence of pulmonary hypertension
(PHT) (SPAP 950 mmHg) at rest seem to be associated with a poor prognosis
[10, 11] and a higher mortality rate after valve replacement [12]. Moreover,
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elevated SPAP and PHT at rest represent an independent predictor of hospital
mortality and post-operative major adverse cardiovascular and cerebrovascular
events [13]. The inconvenience is that, although an easy to assess parameter by
resting echocardiography, when present, PHT is often associated with the
presence of symptoms, which limits its usefulness for clinical decision making.
In contrast, exercise PHT is generally considered as a predictor of occurrence of
resting PHT during the follow-up, development of symptoms, and/or outcome
in various cardiac diseases, including valvular heart disease [14, 15]. We have
previously reported the results of 105 “truly” asymptomatic consecutive pa-
tients with severe AS in whom exercise echocardiography was performed to
identify the changes in SPAP during exercise [16]. Whereas only 6% of the
population exhibited resting PHT (SPAP 950 mmHg), 55% of patients devel-
oped exercise PHT (SPAP 960mmHg). Exercise PHTwasmainly determined by
resting SPAP and male gender, but also by exercise parameters of diastolic
dysfunction (exercise indexed LV end-diastolic volume, exercise e′-wave velocity
and exercise-induced changes in indexed left atrial area). Moreover, exercise
PHT was independently associated with a twofold increase in risk of cardiac
event at 3-year follow-up. All 7 cardiovascular deaths (3 sudden deaths and 4
deaths following heart failure requiring hospitalization) reported in this series,
occurred in the group of patients with exercise PHT, whereas only 1 patient died
from the group with resting PHT. Practically, the measurement of SPAP
throughout the exercise could provide useful additive information. However,
the dynamic changes in SPAP and the occurrence of exercise PHT should be
cautiously interpreted and analyzed in light of age, exercise load, and changes in
systemic blood pressure and in cardiac output.
Evaluation of the respiratory gas-exchange during exercise and the measure-
ment of peak maximal oxygen uptake (VO2) may be of interest in AS patients.
In a recent bi-centric study, we have shown that asymptomatic patients with AS
might have a reduced maximal exercise capacity, even in the absence of LV
dysfunction or abnormal exercise response (in terms of symptoms, blood
pressure, or electrical changes) [17]. Indeed, close to one-half of our patients
had markedly reduced (G84%) age- and sex-predicted peak VO2. Furthermore,
the main determinant of impaired maximal exercise capacity was elevated
global LV hemodynamic afterload (i.e., valvulo-arterial impedance, a surrogate
of both valvular and arterial load faced by the LV). Therefore, the measurement
of peak VO2 may provide an objective parameter allowing a better assessment
of the symptomatic status and unmasking patients who deny symptoms or
adapt their life-style to their condition. However, the relationship between
decreased maximal exercise capacity in asymptomatic AS patients and outcome
requires clarification and further studies.
What is new
Three interesting studies, two of them using ESE and hemodynamic invasive
measurements in symptomatic patients with low or high gradient AS, respec-
tively, and another study using post treadmill exercise echocardiography have
been published in the past year with interesting results [18••, 19, 20••].
All of these studies reinforce the finding that exercise testing is safe in
asymptomatic patients with severe AS, with none of the studies reporting
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untoward events during or after the exercise test in this high risk population.
Lumley et al. and Perez del Villar et al. shown that supine bicycle exercise testing
during cardiac catheterization in patients with severe AS studied prior to AVR,
and thus, symptomatic, is feasible and safe [18••, 20••]. The study of Perez del
Villar et al. is also interesting from the safety point of view because it enrolled
patients with self-reported dyspnea of NYHA class II and III [18••]. Despite the
fact that NYHA class II–III patients have been enrolled, no adverse events have
been recorded. Hence, ESE is safe, even in mildly symptomatic patients with
severe AS, in experienced hands. In our view based on our experience with ESE,
this may be related to the fact that ESE is a highly controlled type of exercise
testing with continuous patient status monitoring including heart rate, blood
pressure response, evaluation of LV function response, and continuous moni-
toring of systolic pulmonary pressure. In this setting, the physician will imme-
diately stop exercise testing in a dyspneic patient in whom new wall motion
abnormalities and/or LV systolic dysfunction and/or exercise-induced pulmo-
nary hypertension are observed. In our opinion, this is one of the important
advantages of ESE over post exercise echocardiography, and this may partially
explain the low adverse event rate with ESE inmildly symptomatic patients with
severe AS in these studies [18••, 20••]. Of course, syncope, especially during
exercise or typical angina remain contraindications for exercise stress testing.
Masri et al. retrospectively analyzed the data from 533 prospectively en-
rolled patients with asymptomatic severe AS with preserved LVEF (i.e.
LVEF 9 50%), defined by an indexed AVA of G0.6 cm2/m2 who underwent
treadmill exercise testing [19]. Post exercise Doppler echocardiography data
have been collected in some of the patients and in 281patients (53%) post
exercisemean gradient was available. The first interesting finding of this study is
that of all patients considered “asymptomatic” by history taking, only 50%were
able to carry on the exercise treadmill to 9100% (excellent exercise capacity),
24% achieved between 85 to 100% and 26% achieved G85% age-sex-predicted
METs. Almost 19% of all patients developed symptoms (dyspnea, angina,
dizziness, abnormal BP or arrhythmias) and patients who achieved G85% age
and sex-predicted METs were more likely to develop symptoms. To note,
severity of AS in this study was defined based on an AVA G 0.6 cm2/m2 and
some of the patients had a BMI 9 25 kg/m2 which in combination with the fact
that in the whole cohort the average peak velocity was G4 m/s may imply that
somepatients hadmoderate to severe forms of AS. If all patients in the spectrum
of moderate to severe AS were part of the group with excellent/preserved
exercise capacity, it means that in the actual population with severe AS a lower
percentage of patients would have been able to achieve 9100% age sex-
predicted METs.
The main finding of the study was that lower % age and sex-predicted METs
and slower heart rate recovery (defined as the drop in heart rate from peak to
1 min post exercise) along with a higher STS score were associated with higher
long-termmortality [19]. As opposed to other studies [5, 6], in the subgroup of
281 patients in whom post exercise stress mean gradient was available, only
17% of patients had 920 mmHg increase in gradient after exercise and this
increase was not associated with longer-term mortality. To understand the
discrepancies with previous reports and the clinical implications of these results,
a careful review of the methodology used in the present study is necessary. First,
only 17% of the 281 patients had an increase in mean gradient with exercise of
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920 mmHg. In the whole cohort, the mean gradient after exercise was only
44 ± 12mmHg, as opposed to what was reported in previous studies. If only the
study of Lancellotti et al. is considered for comparison [6], since it included
patients with severe AS (i.e. AVA G 1.0 cm2), the mean gradient during exercise
was considerably higher as compared to the study ofMasri et al. (53 ± 15mmHg
in patients without events at follow-up and 60 ± 11mmHg in those with events
during follow-up vs. 44 ± 12 mmHg in the study of Masri et al.) [6, 19]. In our
view, this difference relates to the fact that in the study of Masri et al., mean
gradient was recorded during the recovery period after exercise and not at peak
exercise. In our experience, the increase in gradient with exercise may be short-
lived after exercise cessation. Moreover, from the methodology section, it
appears that immediately after exercise the echo exam focus was set on regional
wallmotion abnormalities for evaluation of ischemia and peak right ventricular
systolic pressure, while transaortic velocity and gradients were evaluated later in
the time course of the evaluation. Interestingly, post exercise right ventricular
systolic pressure was similar in patients with age and sex-predictedMETs ≥85 vs.
G85%, although patients with age and sex-predicted METs G85% were those
more likely to present with symptoms during exercise, again a slightly discor-
dant result as compared to studies looking at right ventricular systolic pressure
assessment during exercise [16]. Close scrutiny of the data shows that some of
the patients achieving 985% of age-sex predicted METs did, indeed, develop
symptoms during treadmill exercise testing, and there is an open question
whether some of the patients developing symptoms were also the ones who
have reached more than 100% of age and sex-predicted METs. Interesting data
on AS population come also from the study of Perez del Villar et al., in low-
gradient AS patients (20 patients with AS, LVEF 950%, AVA G1.0 cm2 or
AVA G 0.6 cm2/m2 and a mean gradient G40 mmHg) who aimed to cast a light
into its complicated pathophysiology with the help of combined exercise
testing (during exercise echocardiography and during exercise catheterization).
This study proves that in the correct setting, not only Doppler data can be
assessed during exercise echocardiography but also hemodynamic measure-
ments in a safe way, even in patients with mild symptoms (class II NYHA
dyspnea in 19 patients, 1 patient with class III). Fifty percent of the studied
population had a low-flow low-gradient AS, (SVi G 35 ml/m2) while the other
half had normal-flow low-gradient AS (mean gradient G40 mmHg but
SVi ≥ 35 ml/m2). Symptom development during exercise was not reported in
this study, although authors do emphasize that exercise was symptom-limited.
No patient had a drop in blood pressure with exercise, or an increase in systolic
blood pressure of less than 20 mmHg. Interestingly, by invasive hemodynamic
measurements, 80% of patients developed increased left atrial pressure (PCWP
916mmHg). It would have been interesting to report the percentage of patients
with an increase in left atrial pressure with exercise who stopped their exercise
due to dyspnea and the agreement between invasively measured systolic pul-
monary artery pressure and non-invasive Doppler method during
exercise. No information was provided regarding the tissue Doppler
parameter E/e′ ratio considered a surrogate marker of elevated LV filling
pressure with exercise. However, meaningful information can be
retained from this study: (1) the more rapid the increase in
capillary wedge pressure during exercise, the lower the maximal exercise
capacity; (2) the best independent predictors of the increase in PCWP
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were the capacity to increase aortic valve compliance and the capacity to
increase arterial compliance, but no rest echocardiographic parameters of
valve stenosis severity or LV function; and (3) the patients with the
greatest limitation of maximal exercise capacity had stiffer valves. How-
ever, type 2 error cannot be ruled out in such a small subject sample.
The most important message of the study was that stenotic valves at rest
may still have an “opening reserve” which in turn determines the degree
of functional impairment in an individual patient during exercise.
The third study on exercise testing and AS that is worth mentioning is the
study of Lumley et al. [20••]. This study has shown that invasive coronary
physiological evaluation can be safely performed during exercise and hyper-
emia in patients with AS and that myocardial ischemia in AS is not related to
microvascular disease, but rather to abnormal cardiac-coronary coupling. This
was an elegant study that was performed during exercise catheterization in 22
patients with high gradient severe AS referred for surgery and compared to 38
healthy controls. Refined analysis of coronary blood flow using a dual pressure
and Doppler sensor-tipped intracoronary wire was performed to assess coro-
nary pressure and flow velocity and to derive information on microvascular
resistance throughout the cardiac cycle, at rest, during exercise and also during
hyperemic state. AS patients and 17 consecutive control patients were also
examined with exercise echocardiography. The main findings of the study were
(1) the mechanisms of coronary blood flow increase during exercise are funda-
mentally different from adenosine induced hyperemia; (2) symptomatic pa-
tients with severe AS failed to adapt their coronary blood flow to the increase in
cardiac work, thus making the myocardium more vulnerable to ischemia; (3)
minimummicrovascular resistance in severe ASwas not different from controls,
supporting the hypothesis that microvascular disease is not a factor of reduced
coronary flow reserve; (4) although the efficiency of the healthy heart improved
during exercise and hyperemia due to an increase in the contribution of waves
that accelerate coronary flow, the opposite was observed in severe AS due to an
increase in the contribution of waves that decelerate flow. In the light of this
elegant study, one may conclude that abnormal cardiac-coronary coupling
(abnormal coronary pressure-flow physiology with exaggerated systolic
pressure-flow deceleration waves together with a reduced diastolic perfusion
time) is very likely to be responsible for myocardial ischemia in symptomatic
patients with severe high gradient AS. However, one may need to bear in mind
that these results may be applicable only to patients with “pure” forms of high
gradient AS, since authors have excluded patients without important comor-
bidities, with coronary artery disease and LVEF G50%. Nonetheless, the findings
of this study are helpful to understand that development of wall motion
abnormalities during exercise testing in patients with severe AS may not reflect
flow obstructive coronary artery disease (Fig. 1).
Exercise testing and exercise stress imaging in aortic
regurgitation
Exercise testing is reasonable in asymptomatic patients with severe AR, but no
class indication can be given in the clinical practice guidelines, since there are
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few studies that have addressed this issue [21, 22]. When exercise testing is
performed together with echocardiographic examination, the focus should be
set on the evaluation of LV function and pulmonary artery pressure estimation
with Doppler. Limited data support the use of exercise echocardiography in
asymptomatic AR. Wahi et al. have reported that contractile reserve as assessed
with exercise echocardiography (decrease in LVEF by 5% with exercise) was a
better predictor of LV systolic dysfunction after AVR than resting indices of LV
V max 5.3m/s
MG 68 mmHg

















Fig. 1. a Top. b bottom. A 75-year-old active and asymptomatic patient with severe AS presented for evaluation in our heart valve
clinic. High gradient severe AS with preserved LVEF has been confirmed (a). There is a 20-mmHg increase in mean gradient and no
significant increase in systolic pulmonary artery pressure in the first step of the exercise. At peak stress exercise, there is a decrease
in mean transaortic gradient, paralleled by the development of new wall motion abnormalities (see Movie 1) and increase in
pulmonary artery pressure. Importantly, systolic blood pressure increased less than 20 mmHg during exercise and coronary
angiography did not show any significant stenosis of the coronary arteries. LVOTd left ventricular outflow tract diameter, AVA aortic
valve area by continuity equation, Svi stroke volume index, V maxmaximal transvalvular velocity,MGmean transaortic gradient, TTG
systolic trans-tricuspid gradient, E/e′ the ration between E-peak early diastolic wave velocity of the trans-mitral diastolic flow and
the early peak diastolic velocity measured at the medial mitral annulus with tissue Doppler.
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function. This was studied in asymptomatic patients or patients with minimal
symptoms [21].
Newer studies on aortic valve regurgitation during exercise testing remain
scarce. Broch et al. have investigated 66 asymptomatic patients with moderate
to severe aortic regurgitation, preserved LVEF (i.e. LVEF 9 50%) and without
marked LV dilatation (i.e. end-diastolic LV diameter G 70 mm or end-systolic LV
diameter G 50 mm) who performed an exercise stress treadmill test with mea-
surement of peak oxygen consumption [23]. In this cohort, high oxygen con-
sumption was associated with the presence of a large end-diastolic LV volume, as
assessed by CMR, a low resting heart rate and higher levels of circulating natri-
uretic peptides, while aortic regurgitation severity was not predictive of poorer
maximal exercise capacity. The authors concluded that these patients have a fairly
goodmaximal exercise capacity (mean peak VO2 in the cohort 25.8 ± 8.9 ml/kg)
and that LV dilatation is mainly an adaptative mechanism. However, an increase
in the level of natriuretic peptides seems to be a more sensitive marker of
decreased exercise capacity in such patients. The influence of these parameters
on patients outcome has not been reported merit further investigation.
Conclusion and future directions
The use of exercise testing in aortic valve disease is safe in asymptomatic patients
and should be encouraged especially in heart valve clinics in experienced hands
to understand the complex response of the left ventricle during exercise. The
combination of hemodynamic assessment and imaging has been shown to
better stratify risk. Large-scale studies are mandatory to fully validate ESE in the
setting of aortic valve diseases.
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